SCHEMBL24118250

SCHEMBL24118250

C=C(CCNC(=O)c1cccc(C(F)(F)F)c1)[C@@H](C)C(=O)Nc1ccc(F)cc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.54
▸ POLB P06746 1/20 0.54
▸ TP53BP1 Q12888 1/20 0.49
▸ PTGS1 P23219 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ DDR1 Q08345 4/20 0.47
▸ EPHX2 P34913 1/20 0.46
▸ GPR139 Q6DWJ6 1/20 0.45
▸ RHOC P08134 1/20 0.45
▸ RHOA P61586 1/20 0.45
▸ HDAC3 O15379 2/20 0.45
▸ HDAC1 Q13547 2/20 0.45
▸ HDAC2 Q92769 1/20 0.45
▸ P2RX1 P51575 1/20 0.45
▸ MEN1 O00255 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24118075 0.86 USP36 (0.45) LMNADDR1EPHX2RHOCRHOA
SCHEMBL24118303 0.85 GPR139 (0.48) EPHX2GPR139HDAC3HDAC1RAB9A
SCHEMBL24117943 0.84 EPHX2 (0.43) ALDH1A1LMNADDR1EPHX2RHOC
SCHEMBL24118272 0.83 MEN1 (0.44) ALDH1A1POLBRHOCRHOAMEN1
SCHEMBL24118071 0.82 POLB (0.54) ALDH1A1POLBTP53BP1PTGS1NPSR1
SCHEMBL24117949 0.82 IDO1 (0.53) ALDH1A1POLBHDAC3HDAC1HDAC2
SCHEMBL23593328 0.82 RHOC (0.45) ALDH1A1POLBNPSR1RHOCRHOA
SCHEMBL24118248 0.82 POLB (0.56) POLBLMNAHDAC3HDAC1HDAC2
SCHEMBL24118232 0.81 EPHX2 (0.43) POLBEPHX2MEN1KMT2A
SCHEMBL24118386 0.81 MEN1 (0.42) ALDH1A1POLBRHOCRHOAHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210393600-A1 Novel [1.1.1] Bicyclo Compounds as Indoleamine 2,3-Dioxygenase Inhibitors MERCK SHARP & DOHME CORP. (US) 2021-12-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210393600-A1 Novel [1.1.1] Bicyclo Compounds as Indoleamine 2,3-Dioxygenase Inhibitors IDO1, IDO2, TPH1 ALDH1A1 144/4885POLB 1950/4885TP53BP1 4289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback